SCM

Silverarc Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+470.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$691M
AUM Growth
+$420K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$23.5M
2
+$19.8M
3
+$14.1M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PFE icon
Pfizer
PFE
+$10.6M

Top Sells

1
+$36.8M
2
+$30.6M
3
+$24.8M
4
INSM icon
Insmed
INSM
+$24.7M
5
CDTX
Cidara Therapeutics
CDTX
+$21.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
51
Kymera Therapeutics
KYMR
$6.7B
$2.69M 0.39%
+34,589
NXTC icon
52
NextCure
NXTC
$22.4M
$2.5M 0.36%
+176,057
ELUT icon
53
Elutia
ELUT
$51.3M
$1.91M 0.28%
2,751,314
-99,673
SION
54
Sionna Therapeutics
SION
$1.93B
$1.71M 0.25%
41,460
-67,341
CTMX icon
55
CytomX Therapeutics
CTMX
$784M
$1.64M 0.24%
+385,974
XFOR icon
56
X4 Pharmaceuticals
XFOR
$407M
$1.43M 0.21%
+357,387
EWTX icon
57
Edgewise Therapeutics
EWTX
$3.68B
$1.04M 0.15%
+42,052
RADX
58
Radiopharm Theranostics
RADX
$36.1M
$978K 0.14%
187,406
FDMT icon
59
4D Molecular Therapeutics
FDMT
$518M
$750K 0.11%
+100,000
ADGM
60
Adagio Medical Holdings
ADGM
$16.1M
$536K 0.08%
+515,384
RAPP
61
Rapport Therapeutics
RAPP
$1.89B
$293K 0.04%
9,659
-194,287
PALI icon
62
Palisade Bio
PALI
$368M
$240K 0.03%
+102,108
IBIO icon
63
iBio
IBIO
$94.4M
$205K 0.03%
+106,000
RCKTW icon
64
Rocket Pharmaceuticals Warrant
RCKTW
$2.55K ﹤0.01%
104,828
ARCT icon
65
Arcturus Therapeutics
ARCT
$225M
– –
-3,445
BDSX icon
66
Biodesix
BDSX
$169M
– –
-49,607
CAMP icon
67
CAMP4 Therapeutics
CAMP
$228M
– –
-653,594
IMVT icon
68
Immunovant
IMVT
$6.84B
– –
-50,000
KNSA icon
69
Kiniksa Pharmaceuticals
KNSA
$3.72B
– –
-88,910
MLTX icon
70
MoonLake Immunotherapeutics
MLTX
$1.41B
– –
-30,000
MODD icon
71
Modular Medical
MODD
$26.9M
– –
-21,318
MRSN
72
DELISTED
Mersana Therapeutics
MRSN
– –
-133,636
NKTR icon
73
Nektar Therapeutics
NKTR
$2.19B
– –
-365
PHVS icon
74
Pharvaris
PHVS
$2.11B
– –
-183,903
AKRO
75
DELISTED
Akero Therapeutics
AKRO
– –
-643,636
1 2
3
4